866-997-4948(US-Canada Toll Free)

Global Dengue Vaccine Sales Market Report 2018

Published By :

QYResearch

Published Date : Jul 2018

Category :

Pharmaceutical

No. of Pages : 104 Pages

This report studies the global Dengue Vaccine market status and forecast, categorizes the global Dengue Vaccine market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

The Aedes aegypti mosquito is responsible for transmitting the dengue virus (DENV). The virus that causes dengue belongs to the Flavivirus genus of the Flaviviridae family. Dengue fever resembles influenza and affects adults, children, as well as infants, but it is rarely fatal. However, dengue hemorrhagic fever is a potentially fatal complication because of multiple factors such as fluid accumulation, severe bleeding, organ impairment, or plasma leaking.
With the increasing population density and global warming, there is a rapid growth in the prevalence of dengue, especially in the tropical and subtropical regions across the world. According to the National Institute of Health, approximately 0.05 to 0.2 billion cases of dengue infections are reported annually and the mortality rate due to dengue was above 20,000. The report has identified the rapid growth in disease incidences as one of the primary factors that will fuel the growth of the dengue vaccine market in the coming years. The prevalence of dengue is present in more than 125 countries across the world and the rising prevalence of dengue will drive the market during the forecast period.
The dengue vaccine market is marginally concentrated due to the presence and dominance of the established players. Several companies are investing in R&D to develop more advanced products and expand their product portfolio. Several organizations are merging for research and making enormous efforts to develop vaccines that can challenge the Sanofi Pasteur's exclusivity in the dengue treatment market. Moreover, several organizations are making huge investments in R&D to develop novel treatment options.
The Americas will be the major revenue contributor to the dengue vaccine market owing to the increasing incidences of dengue cases. The dengue treatment market in the Americas will profit from the bilateral program, Indo-U.S. Vaccine Action Program (VAP), which is concentrated on activities related to immunization and vaccine-related research.
The global Dengue Vaccine market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major players covered in this report
GlaxoSmithKline
Merck Sharp & Dohme
Sanofi
Takeda Pharmaceuticals
GeneOne Life Sciences
Medigen Biologics
Panacea Biotec
Sun Pharmaceutical
U.S NIH
Vabiotec

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
CYD-TDV
DENVax or TAK-003
TetraVax-DV
TDENV PIV
V180
DNA vaccines
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Government institutions
Hospitals
NGOs

The study objectives of this report are:
To analyze and study the global Dengue Vaccine sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Dengue Vaccine players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Dengue Vaccine are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Dengue Vaccine Manufacturers
Dengue Vaccine Distributors/Traders/Wholesalers
Dengue Vaccine Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Dengue Vaccine market, by end-use.
Detailed analysis and profiles of additional market players.
Table of Contents

Global Dengue Vaccine Sales Market Report 2018
1 Dengue Vaccine Market Overview
1.1 Product Overview and Scope of Dengue Vaccine
1.2 Classification of Dengue Vaccine by Product Category
1.2.1 Global Dengue Vaccine Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Dengue Vaccine Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 CYD-TDV
1.2.4 DENVax or TAK-003
1.2.5 TetraVax-DV
1.2.6 TDENV PIV
1.2.7 V180
1.2.8 DNA vaccines
1.3 Global Dengue Vaccine Market by Application/End Users
1.3.1 Global Dengue Vaccine Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.1 Government institutions
1.3.2 Hospitals
1.3.3 NGOs
1.4 Global Dengue Vaccine Market by Region
1.4.1 Global Dengue Vaccine Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Dengue Vaccine Status and Prospect (2013-2025)
1.4.3 Europe Dengue Vaccine Status and Prospect (2013-2025)
1.4.4 China Dengue Vaccine Status and Prospect (2013-2025)
1.4.5 Japan Dengue Vaccine Status and Prospect (2013-2025)
1.4.6 Southeast Asia Dengue Vaccine Status and Prospect (2013-2025)
1.4.7 India Dengue Vaccine Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Dengue Vaccine (2013-2025)
1.5.1 Global Dengue Vaccine Sales and Growth Rate (2013-2025)
1.5.2 Global Dengue Vaccine Revenue and Growth Rate (2013-2025)

2 Global Dengue Vaccine Competition by Players/Suppliers, Type and Application
2.1 Global Dengue Vaccine Market Competition by Players/Suppliers
2.1.1 Global Dengue Vaccine Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Dengue Vaccine Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Dengue Vaccine (Volume and Value) by Type
2.2.1 Global Dengue Vaccine Sales and Market Share by Type (2013-2018)
2.2.2 Global Dengue Vaccine Revenue and Market Share by Type (2013-2018)
2.3 Global Dengue Vaccine (Volume and Value) by Region
2.3.1 Global Dengue Vaccine Sales and Market Share by Region (2013-2018)
2.3.2 Global Dengue Vaccine Revenue and Market Share by Region (2013-2018)
2.4 Global Dengue Vaccine (Volume) by Application

3 United States Dengue Vaccine (Volume, Value and Sales Price)
3.1 United States Dengue Vaccine Sales and Value (2013-2018)
3.1.1 United States Dengue Vaccine Sales and Growth Rate (2013-2018)
3.1.2 United States Dengue Vaccine Revenue and Growth Rate (2013-2018)
3.1.3 United States Dengue Vaccine Sales Price Trend (2013-2018)
3.2 United States Dengue Vaccine Sales Volume and Market Share by Players (2013-2018)
3.3 United States Dengue Vaccine Sales Volume and Market Share by Type (2013-2018)
3.4 United States Dengue Vaccine Sales Volume and Market Share by Application (2013-2018)

4 Europe Dengue Vaccine (Volume, Value and Sales Price)
4.1 Europe Dengue Vaccine Sales and Value (2013-2018)
4.1.1 Europe Dengue Vaccine Sales and Growth Rate (2013-2018)
4.1.2 Europe Dengue Vaccine Revenue and Growth Rate (2013-2018)
4.1.3 Europe Dengue Vaccine Sales Price Trend (2013-2018)
4.2 Europe Dengue Vaccine Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Dengue Vaccine Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Dengue Vaccine Sales Volume and Market Share by Application (2013-2018)

5 China Dengue Vaccine (Volume, Value and Sales Price)
5.1 China Dengue Vaccine Sales and Value (2013-2018)
5.1.1 China Dengue Vaccine Sales and Growth Rate (2013-2018)
5.1.2 China Dengue Vaccine Revenue and Growth Rate (2013-2018)
5.1.3 China Dengue Vaccine Sales Price Trend (2013-2018)
5.2 China Dengue Vaccine Sales Volume and Market Share by Players (2013-2018)
5.3 China Dengue Vaccine Sales Volume and Market Share by Type (2013-2018)
5.4 China Dengue Vaccine Sales Volume and Market Share by Application (2013-2018)

6 Japan Dengue Vaccine (Volume, Value and Sales Price)
6.1 Japan Dengue Vaccine Sales and Value (2013-2018)
6.1.1 Japan Dengue Vaccine Sales and Growth Rate (2013-2018)
6.1.2 Japan Dengue Vaccine Revenue and Growth Rate (2013-2018)
6.1.3 Japan Dengue Vaccine Sales Price Trend (2013-2018)
6.2 Japan Dengue Vaccine Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Dengue Vaccine Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Dengue Vaccine Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Dengue Vaccine (Volume, Value and Sales Price)
7.1 Southeast Asia Dengue Vaccine Sales and Value (2013-2018)
7.1.1 Southeast Asia Dengue Vaccine Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Dengue Vaccine Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Dengue Vaccine Sales Price Trend (2013-2018)
7.2 Southeast Asia Dengue Vaccine Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Dengue Vaccine Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Dengue Vaccine Sales Volume and Market Share by Application (2013-2018)

8 India Dengue Vaccine (Volume, Value and Sales Price)
8.1 India Dengue Vaccine Sales and Value (2013-2018)
8.1.1 India Dengue Vaccine Sales and Growth Rate (2013-2018)
8.1.2 India Dengue Vaccine Revenue and Growth Rate (2013-2018)
8.1.3 India Dengue Vaccine Sales Price Trend (2013-2018)
8.2 India Dengue Vaccine Sales Volume and Market Share by Players (2013-2018)
8.3 India Dengue Vaccine Sales Volume and Market Share by Type (2013-2018)
8.4 India Dengue Vaccine Sales Volume and Market Share by Application (2013-2018)

9 Global Dengue Vaccine Players/Suppliers Profiles and Sales Data
9.1 GlaxoSmithKline
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Dengue Vaccine Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 GlaxoSmithKline Dengue Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 Merck Sharp & Dohme
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Dengue Vaccine Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Merck Sharp & Dohme Dengue Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 Sanofi
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Dengue Vaccine Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Sanofi Dengue Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 Takeda Pharmaceuticals
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Dengue Vaccine Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Takeda Pharmaceuticals Dengue Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 GeneOne Life Sciences
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Dengue Vaccine Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 GeneOne Life Sciences Dengue Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview
9.6 Medigen Biologics
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Dengue Vaccine Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Medigen Biologics Dengue Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
9.6.4 Main Business/Business Overview
9.7 Panacea Biotec
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Dengue Vaccine Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Panacea Biotec Dengue Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
9.7.4 Main Business/Business Overview
9.8 Sun Pharmaceutical
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Dengue Vaccine Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Sun Pharmaceutical Dengue Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
9.8.4 Main Business/Business Overview
9.9 U.S NIH
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Dengue Vaccine Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 U.S NIH Dengue Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
9.9.4 Main Business/Business Overview
9.10 Vabiotec
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Dengue Vaccine Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Vabiotec Dengue Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
9.10.4 Main Business/Business Overview

10 Dengue Vaccine Maufacturing Cost Analysis
10.1 Dengue Vaccine Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Dengue Vaccine
10.3 Manufacturing Process Analysis of Dengue Vaccine

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Dengue Vaccine Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Dengue Vaccine Major Manufacturers in 2017
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Dengue Vaccine Market Forecast (2018-2025)
14.1 Global Dengue Vaccine Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Dengue Vaccine Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Dengue Vaccine Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Dengue Vaccine Price and Trend Forecast (2018-2025)
14.2 Global Dengue Vaccine Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Dengue Vaccine Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Dengue Vaccine Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Dengue Vaccine Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Dengue Vaccine Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Dengue Vaccine Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Dengue Vaccine Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Dengue Vaccine Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Dengue Vaccine Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Dengue Vaccine Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Dengue Vaccine Sales Forecast by Type (2018-2025)
14.3.2 Global Dengue Vaccine Revenue Forecast by Type (2018-2025)
14.3.3 Global Dengue Vaccine Price Forecast by Type (2018-2025)
14.4 Global Dengue Vaccine Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Table

List of Tables and Figures

Figure Product Picture of Dengue Vaccine
Figure Global Dengue Vaccine Sales Volume Comparison (K Units) by Type (2013-2025)
Figure Global Dengue Vaccine Sales Volume Market Share by Type (Product Category) in 2017
Figure CYD-TDV Product Picture
Figure DENVax or TAK-003 Product Picture
Figure TetraVax-DV Product Picture
Figure TDENV PIV Product Picture
Figure V180 Product Picture
Figure DNA vaccines Product Picture
Figure Global Dengue Vaccine Sales Comparison (K Units) by Application (2013-2025)
Figure Global Sales Market Share of Dengue Vaccine by Application in 2017
Figure Government institutions Examples
Table Key Downstream Customer in Government institutions
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure NGOs Examples
Table Key Downstream Customer in NGOs
Figure Global Dengue Vaccine Market Size (Million USD) by Regions (2013-2025)
Figure United States Dengue Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Dengue Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Dengue Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Dengue Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Dengue Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Dengue Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Dengue Vaccine Sales Volume (K Units) and Growth Rate (2013-2025)
Figure Global Dengue Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Dengue Vaccine Sales Volume (K Units) (2013-2018)
Table Global Dengue Vaccine Sales (K Units) of Key Players/Suppliers (2013-2018)
Table Global Dengue Vaccine Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Dengue Vaccine Sales Share by Players/Suppliers
Figure 2017 Dengue Vaccine Sales Share by Players/Suppliers
Figure Global Dengue Vaccine Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Dengue Vaccine Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Dengue Vaccine Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Dengue Vaccine Revenue Share by Players
Table 2017 Global Dengue Vaccine Revenue Share by Players
Table Global Dengue Vaccine Sales (K Units) and Market Share by Type (2013-2018)
Table Global Dengue Vaccine Sales Share (K Units) by Type (2013-2018)
Figure Sales Market Share of Dengue Vaccine by Type (2013-2018)
Figure Global Dengue Vaccine Sales Growth Rate by Type (2013-2018)
Table Global Dengue Vaccine Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Dengue Vaccine Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Dengue Vaccine by Type (2013-2018)
Figure Global Dengue Vaccine Revenue Growth Rate by Type (2013-2018)
Table Global Dengue Vaccine Sales Volume (K Units) and Market Share by Region (2013-2018)
Table Global Dengue Vaccine Sales Share by Region (2013-2018)
Figure Sales Market Share of Dengue Vaccine by Region (2013-2018)
Figure Global Dengue Vaccine Sales Growth Rate by Region in 2017
Table Global Dengue Vaccine Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Dengue Vaccine Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Dengue Vaccine by Region (2013-2018)
Figure Global Dengue Vaccine Revenue Growth Rate by Region in 2017
Table Global Dengue Vaccine Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Dengue Vaccine Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Dengue Vaccine by Region (2013-2018)
Figure Global Dengue Vaccine Revenue Market Share by Region in 2017
Table Global Dengue Vaccine Sales Volume (K Units) and Market Share by Application (2013-2018)
Table Global Dengue Vaccine Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Dengue Vaccine by Application (2013-2018)
Figure Global Dengue Vaccine Sales Market Share by Application (2013-2018)
Figure United States Dengue Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure United States Dengue Vaccine Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Dengue Vaccine Sales Price (USD/Unit) Trend (2013-2018)
Table United States Dengue Vaccine Sales Volume (K Units) by Players (2013-2018)
Table United States Dengue Vaccine Sales Volume Market Share by Players (2013-2018)
Figure United States Dengue Vaccine Sales Volume Market Share by Players in 2017
Table United States Dengue Vaccine Sales Volume (K Units) by Type (2013-2018)
Table United States Dengue Vaccine Sales Volume Market Share by Type (2013-2018)
Figure United States Dengue Vaccine Sales Volume Market Share by Type in 2017
Table United States Dengue Vaccine Sales Volume (K Units) by Application (2013-2018)
Table United States Dengue Vaccine Sales Volume Market Share by Application (2013-2018)
Figure United States Dengue Vaccine Sales Volume Market Share by Application in 2017
Figure Europe Dengue Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Dengue Vaccine Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Dengue Vaccine Sales Price (USD/Unit) Trend (2013-2018)
Table Europe Dengue Vaccine Sales Volume (K Units) by Players (2013-2018)
Table Europe Dengue Vaccine Sales Volume Market Share by Players (2013-2018)
Figure Europe Dengue Vaccine Sales Volume Market Share by Players in 2017
Table Europe Dengue Vaccine Sales Volume (K Units) by Type (2013-2018)
Table Europe Dengue Vaccine Sales Volume Market Share by Type (2013-2018)
Figure Europe Dengue Vaccine Sales Volume Market Share by Type in 2017
Table Europe Dengue Vaccine Sales Volume (K Units) by Application (2013-2018)
Table Europe Dengue Vaccine Sales Volume Market Share by Application (2013-2018)
Figure Europe Dengue Vaccine Sales Volume Market Share by Application in 2017
Figure China Dengue Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure China Dengue Vaccine Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Dengue Vaccine Sales Price (USD/Unit) Trend (2013-2018)
Table China Dengue Vaccine Sales Volume (K Units) by Players (2013-2018)
Table China Dengue Vaccine Sales Volume Market Share by Players (2013-2018)
Figure China Dengue Vaccine Sales Volume Market Share by Players in 2017
Table China Dengue Vaccine Sales Volume (K Units) by Type (2013-2018)
Table China Dengue Vaccine Sales Volume Market Share by Type (2013-2018)
Figure China Dengue Vaccine Sales Volume Market Share by Type in 2017
Table China Dengue Vaccine Sales Volume (K Units) by Application (2013-2018)
Table China Dengue Vaccine Sales Volume Market Share by Application (2013-2018)
Figure China Dengue Vaccine Sales Volume Market Share by Application in 2017
Figure Japan Dengue Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure Japan Dengue Vaccine Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Dengue Vaccine Sales Price (USD/Unit) Trend (2013-2018)
Table Japan Dengue Vaccine Sales Volume (K Units) by Players (2013-2018)
Table Japan Dengue Vaccine Sales Volume Market Share by Players (2013-2018)
Figure Japan Dengue Vaccine Sales Volume Market Share by Players in 2017
Table Japan Dengue Vaccine Sales Volume (K Units) by Type (2013-2018)
Table Japan Dengue Vaccine Sales Volume Market Share by Type (2013-2018)
Figure Japan Dengue Vaccine Sales Volume Market Share by Type in 2017
Table Japan Dengue Vaccine Sales Volume (K Units) by Application (2013-2018)
Table Japan Dengue Vaccine Sales Volume Market Share by Application (2013-2018)
Figure Japan Dengue Vaccine Sales Volume Market Share by Application in 2017
Figure Southeast Asia Dengue Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure Southeast Asia Dengue Vaccine Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Dengue Vaccine Sales Price (USD/Unit) Trend (2013-2018)
Table Southeast Asia Dengue Vaccine Sales Volume (K Units) by Players (2013-2018)
Table Southeast Asia Dengue Vaccine Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Dengue Vaccine Sales Volume Market Share by Players in 2017
Table Southeast Asia Dengue Vaccine Sales Volume (K Units) by Type (2013-2018)
Table Southeast Asia Dengue Vaccine Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Dengue Vaccine Sales Volume Market Share by Type in 2017
Table Southeast Asia Dengue Vaccine Sales Volume (K Units) by Application (2013-2018)
Table Southeast Asia Dengue Vaccine Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Dengue Vaccine Sales Volume Market Share by Application in 2017
Figure India Dengue Vaccine Sales (K Units) and Growth Rate (2013-2018)
Figure India Dengue Vaccine Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Dengue Vaccine Sales Price (USD/Unit) Trend (2013-2018)
Table India Dengue Vaccine Sales Volume (K Units) by Players (2013-2018)
Table India Dengue Vaccine Sales Volume Market Share by Players (2013-2018)
Figure India Dengue Vaccine Sales Volume Market Share by Players in 2017
Table India Dengue Vaccine Sales Volume (K Units) by Type (2013-2018)
Table India Dengue Vaccine Sales Volume Market Share by Type (2013-2018)
Figure India Dengue Vaccine Sales Volume Market Share by Type in 2017
Table India Dengue Vaccine Sales Volume (K Units) by Application (2013-2018)
Table India Dengue Vaccine Sales Volume Market Share by Application (2013-2018)
Figure India Dengue Vaccine Sales Volume Market Share by Application in 2017
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Dengue Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure GlaxoSmithKline Dengue Vaccine Sales Growth Rate (2013-2018)
Figure GlaxoSmithKline Dengue Vaccine Sales Global Market Share (2013-2018)
Figure GlaxoSmithKline Dengue Vaccine Revenue Global Market Share (2013-2018)
Table Merck Sharp & Dohme Basic Information List
Table Merck Sharp & Dohme Dengue Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Merck Sharp & Dohme Dengue Vaccine Sales Growth Rate (2013-2018)
Figure Merck Sharp & Dohme Dengue Vaccine Sales Global Market Share (2013-2018)
Figure Merck Sharp & Dohme Dengue Vaccine Revenue Global Market Share (2013-2018)
Table Sanofi Basic Information List
Table Sanofi Dengue Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sanofi Dengue Vaccine Sales Growth Rate (2013-2018)
Figure Sanofi Dengue Vaccine Sales Global Market Share (2013-2018
Figure Sanofi Dengue Vaccine Revenue Global Market Share (2013-2018)
Table Takeda Pharmaceuticals Basic Information List
Table Takeda Pharmaceuticals Dengue Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Takeda Pharmaceuticals Dengue Vaccine Sales Growth Rate (2013-2018)
Figure Takeda Pharmaceuticals Dengue Vaccine Sales Global Market Share (2013-2018)
Figure Takeda Pharmaceuticals Dengue Vaccine Revenue Global Market Share (2013-2018)
Table GeneOne Life Sciences Basic Information List
Table GeneOne Life Sciences Dengue Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure GeneOne Life Sciences Dengue Vaccine Sales Growth Rate (2013-2018)
Figure GeneOne Life Sciences Dengue Vaccine Sales Global Market Share (2013-2018)
Figure GeneOne Life Sciences Dengue Vaccine Revenue Global Market Share (2013-2018)
Table Medigen Biologics Basic Information List
Table Medigen Biologics Dengue Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Medigen Biologics Dengue Vaccine Sales Growth Rate (2013-2018)
Figure Medigen Biologics Dengue Vaccine Sales Global Market Share (2013-2018
Figure Medigen Biologics Dengue Vaccine Revenue Global Market Share (2013-2018)
Table Panacea Biotec Basic Information List
Table Panacea Biotec Dengue Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Panacea Biotec Dengue Vaccine Sales Growth Rate (2013-2018)
Figure Panacea Biotec Dengue Vaccine Sales Global Market Share (2013-2018)
Figure Panacea Biotec Dengue Vaccine Revenue Global Market Share (2013-2018)
Table Sun Pharmaceutical Basic Information List
Table Sun Pharmaceutical Dengue Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sun Pharmaceutical Dengue Vaccine Sales Growth Rate (2013-2018)
Figure Sun Pharmaceutical Dengue Vaccine Sales Global Market Share (2013-2018
Figure Sun Pharmaceutical Dengue Vaccine Revenue Global Market Share (2013-2018)
Table U.S NIH Basic Information List
Table U.S NIH Dengue Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure U.S NIH Dengue Vaccine Sales Growth Rate (2013-2018)
Figure U.S NIH Dengue Vaccine Sales Global Market Share (2013-2018)
Figure U.S NIH Dengue Vaccine Revenue Global Market Share (2013-2018)
Table Vabiotec Basic Information List
Table Vabiotec Dengue Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Vabiotec Dengue Vaccine Sales Growth Rate (2013-2018)
Figure Vabiotec Dengue Vaccine Sales Global Market Share (2013-2018)
Figure Vabiotec Dengue Vaccine Revenue Global Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Dengue Vaccine
Figure Manufacturing Process Analysis of Dengue Vaccine
Figure Dengue Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Dengue Vaccine Major Players in 2017
Table Major Buyers of Dengue Vaccine
Table Distributors/Traders List
Figure Global Dengue Vaccine Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Dengue Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Dengue Vaccine Price (USD/Unit) and Trend Forecast (2018-2025)
Table Global Dengue Vaccine Sales Volume (K Units) Forecast by Regions (2018-2025)
Figure Global Dengue Vaccine Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Dengue Vaccine Sales Volume Market Share Forecast by Regions in 2025
Table Global Dengue Vaccine Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Dengue Vaccine Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Dengue Vaccine Revenue Market Share Forecast by Regions in 2025
Figure United States Dengue Vaccine Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Dengue Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Dengue Vaccine Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Dengue Vaccine Revenue and Growth Rate Forecast (2018-2025)
Figure China Dengue Vaccine Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure China Dengue Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Dengue Vaccine Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Dengue Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Dengue Vaccine Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Dengue Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Dengue Vaccine Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure India Dengue Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Dengue Vaccine Sales (K Units) Forecast by Type (2018-2025)
Figure Global Dengue Vaccine Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Dengue Vaccine Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Dengue Vaccine Revenue Market Share Forecast by Type (2018-2025)
Table Global Dengue Vaccine Price (USD/Unit) Forecast by Type (2018-2025)
Table Global Dengue Vaccine Sales (K Units) Forecast by Application (2018-2025)
Figure Global Dengue Vaccine Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *